Literature DB >> 11893753

Evaluation of the role of phosphatidylserine translocase activity in ABCA1-mediated lipid efflux.

Jonathan D Smith1, Christine Waelde, Andrew Horwitz, Ping Zheng.   

Abstract

The following two theories for the mechanism of ABCA1 in lipid efflux to apolipoprotein acceptors have been proposed: 1) that ABCA1 directly binds the apolipoprotein ligand and then facilitates lipid efflux and 2) that ABCA1 acts as a phosphatidylserine (PS) translocase, increasing PS levels in the plasma membrane exofacial leaflet, and that this is sufficient to facilitate apolipoprotein binding and lipid assembly. Upon induction of ABCA1 in RAW264.7 cells by cAMP analogues there was a moderate increase in cell surface PS as detected by annexin V binding, whereas apoAI binding was increased more robustly. Apoptosis induced large increases in annexin V and apoAI binding; however, apoptotic cells did not efflux lipids to apoAI. Annexin V did not act as a cholesterol acceptor, and it did not compete for the cholesterol acceptor or cell binding activity of apoAI. ApoAI binds to ABCA1-expressing cells, and with incubation at 37 degrees C apoAI is co-localized within the cells in ABCA1-containing endosomes. Fluorescent recovery after photobleaching demonstrated that apoAI bound to ABCA1-expressing cells was relatively immobile, suggesting that it was bound either directly or indirectly to an integral membrane protein. Although ABCA1 induction was associated with a small increase in cell surface PS, these results argue against the notion that this cell surface PS is sufficient to mediate cellular apoAI binding and lipid efflux.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893753     DOI: 10.1074/jbc.M201594200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  A novel compound inhibits reconstituted high-density lipoprotein assembly and blocks nascent high-density lipoprotein biogenesis downstream of apolipoprotein AI binding to ATP-binding cassette transporter A1-expressing cells.

Authors:  Nicholas N Lyssenko; Gregory Brubaker; Bradley D Smith; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 3.  The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids.

Authors:  Guo-Jun Zhao; Kai Yin; Yu-Chang Fu; Chao-Ke Tang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 4.  The role of vesicular transport in ABCA1-dependent lipid efflux and its connection with NPC pathways.

Authors:  Emmanuel Boadu; Gordon A Francis
Journal:  J Mol Med (Berl)       Date:  2005-11-17       Impact factor: 4.599

5.  The ins and outs of lipid efflux.

Authors:  Stefan Lorkowski
Journal:  J Mol Med (Berl)       Date:  2008-02       Impact factor: 4.599

6.  The N-terminal 26-residue fragment of human programmed cell death 5 protein can form a stable alpha-helix having unique electrostatic potential character.

Authors:  Dongsheng Liu; Hongwei Yao; Yaoyao Chen; Yingang Feng; Yingyu Chen; Jinfeng Wang
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

7.  Induction of fibroblast apolipoprotein E expression during apoptosis, starvation-induced growth arrest and mitosis.

Authors:  Carmel M Quinn; Katarina Kågedal; Alexei Terman; Uri Stroikin; Ulf T Brunk; Wendy Jessup; Brett Garner
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

8.  An analysis of the role of a retroendocytosis pathway in ABCA1-mediated cholesterol efflux from macrophages.

Authors:  Loren E Faulkner; Stacey E Panagotopulos; Jacob D Johnson; Laura A Woollett; David Y Hui; Scott R Witting; J Nicholas Maiorano; W Sean Davidson
Journal:  J Lipid Res       Date:  2008-03-22       Impact factor: 5.922

9.  Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL.

Authors:  Anny Mulya; Ji-Young Lee; Abraham K Gebre; Elena Y Boudyguina; Soon-Kyu Chung; Thomas L Smith; Perry L Colvin; Xian-Cheng Jiang; John S Parks
Journal:  J Lipid Res       Date:  2008-06-25       Impact factor: 5.922

10.  Brefeldin A inhibits cholesterol efflux without affecting the rate of cellular uptake and re-secretion of apolipoprotein A-I in adipocytes.

Authors:  Philip B Verghese; Estela L Arrese; Alisha D Howard; Jose L Soulages
Journal:  Arch Biochem Biophys       Date:  2008-08-07       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.